Sage Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Sage Therapeutics has a total shareholder equity of $705.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $767.6M and $61.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$717.01m |
Equity | US$705.80m |
Total liabilities | US$61.80m |
Total assets | US$767.60m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SG7's short term assets ($755.4M) exceed its short term liabilities ($61.8M).
Long Term Liabilities: SG7 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: SG7 is debt free.
Reducing Debt: SG7 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SG7 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if SG7 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.